MiRNA-148b and Its Role in Various Cancers

References

• Yu W , LiangX , LiX , ZhangYet al. MicroRNA-195: a review of its role in cancers. Onco. Targets Ther.11, 7109 (2018).
   PubMed Web of Science ®Google Scholar
• Song Y , SunJ , XuYet al. Microarray analysis of long non-coding RNAs related to microRNA-148b in gastric cancer. Neoplasma64(2), 199–208 (2017).
   PubMed Web of Science ®Google Scholar
• Hashemipour M , BoroumandH , MollazadehSet al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol. Oncol.161(1), 314–327 (2021).
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh E , RavanH , MohammadiA , PourghadamyariH. Colorimetric detection of miRNA-21 by DNAzyme-coupled branched DNA constructs. Talanta.216, 120913 (2020).
   PubMed Web of Science ®Google Scholar
• Mardani R , JafariNajaf Abadi MH , MotieianMet al. MicroRNA in leukemia: tumor suppressors and oncogenes with prognostic potential. J. Cell. Physiol.234(6), 8465–8486 (2019).
   PubMed Web of Science ®Google Scholar
• Khani P , NasriF , KhaniChamani Fet al. Genetic and epigenetic contribution to astrocytic gliomas pathogenesis. J. Neurochem.148(2), 188–203 (2019).
   PubMed Web of Science ®Google Scholar
• Shabaninejad Z , YousefiF , MovahedpourAet al. Electrochemical-based biosensors for microRNA detection: nanotechnology comes into view. Anal. Biochem.581, 113349 (2019).
   PubMed Web of Science ®Google Scholar
• Sharma V , MisteliT. Non-coding RNAs in DNA damage and repair. FEBS. Lett.587(13), 1832–1839 (2013).
   PubMed Web of Science ®Google Scholar
• Lee RC , FeinbaumRL , AmbrosV. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell75(5), 843–854 (1993).
   PubMed Web of Science ®Google Scholar
• Si W , ShenJ , ZhengH , FanW. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin. Epigenetics11(1), 1–24 (2019).
   PubMedGoogle Scholar
• Broderick JA , ZamorePD. MicroRNA therapeutics. Gene. Ther.18(12), 1104–1110 (2011).
   PubMed Web of Science ®Google Scholar
• Collino F , BrunoS , DeregibusMCet al. MicroRNAs and mesenchymal stem cells. Vitam. Horm.87, 291–320 (2011).
   PubMed Web of Science ®Google Scholar
• Taipaleenmäki H , HoklandLB , ChenLet al. Micro-RNAs: targets for enhancing osteoblast differentiation and bone formation. Eur. J. Endocrinol.166(3), 359–371 (2012).
   PubMed Web of Science ®Google Scholar
• Kapinas K , DelanyAM. MicroRNA biogenesis and regulation of bone remodeling. Arthritis. Res. Ther.13(3), 1–11 (2011).
   Web of Science ®Google Scholar
• Chen Y , SongYX , WangZN. The microRNA-148/152 family: multi-faceted players. Mol. Cancer.12(1), 1–8 (2013).
   PubMedGoogle Scholar
• Hébert SS , DeStrooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends. Neurosci.32(4), 199–206 (2009).
   PubMed Web of Science ®Google Scholar
• Lin W , WangL , YangSet al. Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma. Oncol. Lett.16(1), 998–1002 (2018).
   PubMed Web of Science ®Google Scholar
• Okugawa Y , GradyWM , GoelA. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology149(5), 1204–1225e12 (2015).
   PubMed Web of Science ®Google Scholar
• Melo SA , EstellerM. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett.585(13), 2087–2099 (2011).
   PubMed Web of Science ®Google Scholar
• Aure MR , LeivonenSK , FleischerTet al. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol.14(11), R126 (2013).
   PubMed Web of Science ®Google Scholar
• Chen Y , SongYX , WangZN. The microRNA-148/152 family: multi-faceted players. Mol. Cancer.12(1), 43 (2013).
   PubMedGoogle Scholar
• Srivastava D , DewittN. In vivo cellular reprogramming: the next generation. Cell166(6), 1386–1396 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang Z , ZhengW , HaiJ. MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis. Med. Oncol.31(6), 984 (2014).
   PubMed Web of Science ®Google Scholar
• Xu P , DuongDM , SeyfriedNTet al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell137(1), 133–145 (2009).
   PubMed Web of Science ®Google Scholar
• Lu J , GetzG , MiskaEAet al. MicroRNA expression profiles classify human cancers. Nature435(7043), 834–838 (2005).
   PubMed Web of Science ®Google Scholar
• Kelly GL , StrasserA. Toward targeting antiapoptotic MCL-1 for cancer therapy. Annu. Rev. Cancer Biol.4, 299–313 (2020).
   Google Scholar
• Ge H , LiB , HuWXet al. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Int. J. Clin. Exp. Pathol.8, 800–805 (2015).
   PubMed Web of Science ®Google Scholar
• Song YX , YueZY , WangZNet al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol. Cancer.10(1), 1 (2011).
   PubMedGoogle Scholar
• Li X , JiangM , ChenDet al. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis. J. Exp. Clin. Cancer Res.37(1), 71 (2018).
   PubMed Web of Science ®Google Scholar
• Ding X , LiuJ , LiuTet al. miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. Cancer. Med.6(6), 1301–1310 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang JG , ShiY , HongDFet al. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway. Sci. Rep.5, 8087 (2015).
   PubMed Web of Science ®Google Scholar
• Liu Q , XuY , WeiSet al. miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1. Biosci. Rep.35(4), (2015).
   Google Scholar
• Ke M , ZhangZ , CongLet al. MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis. Biomed. Pharmacother.120, 109523 (2019).
   PubMed Web of Science ®Google Scholar
• Chen X , BoL , LuWet al. MicroRNA-148b targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in hepatocellular carcinoma. Mol. Med. Rep.13(1), 477–482 (2015).
   PubMed Web of Science ®Google Scholar
• Zhao G , ZhangJG , LiuYet al. miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. Mol. Cancer. Ther.12(1), 83–93 (2013).
   PubMed Web of Science ®Google Scholar
• Azizi M , Teimoori-ToolabiL , ArzananiMKet al. MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. Cancer Biol. Ther.15(4), 419–427 (2014).
   PubMed Web of Science ®Google Scholar
• Chang H , ZhouX , WangZNet al. Increased expression of miR-148b in ovarian carcinoma and its clinical significance. Mol. Med. Rep.5(5), 1277–1280 (2012).
   PubMed Web of Science ®Google Scholar
• Mou Z , XuX , DongM , XuJ. MicroRNA-148b acts as a tumor suppressor in cervical cancer by inducing G1/S-phase cell cycle arrest and apoptosis in a caspase-3-dependent manner. Med. Sci. Monit.22, 2809 (2016).
   PubMed Web of Science ®Google Scholar
• Luo H , LiangC. MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1. Exp. Ther. Med.15(4), 3609–3616 (2018).
   PubMed Web of Science ®Google Scholar
• Kümper S , MardakhehFK , MccarthyAet al. Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis. Elife.5, e12203 (2016).
   PubMed Web of Science ®Google Scholar
• Jiang Z , ZhangJ , ChenF , SunY. MiR-148b suppressed non-small cell lung cancer progression via inhibiting ALCAM through the NF-κB signaling pathway. Thorac. Cancer.11(2), 415–425 (2020).
   PubMed Web of Science ®Google Scholar
• Dhanasekaran DN , ReddyEP. JNK-signaling: a multiplexing hub in programmed cell death. Genes Cancer8(9–10), 682 (2017).
   PubMedGoogle Scholar
• Chen X , WangY-W , GaoP. SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer. J. Exp. Clin. Cancer. Res.37(1), 1–12 (2018).
   PubMedGoogle Scholar
• Sandhu R , RivenbarkAG , ColemanWB. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines. Int. J. Oncol.41(2), 721–732 (2012).
   PubMed Web of Science ®Google Scholar
• Yuan L , LiuY , QuYet al. Exosomes derived from microrna-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression. Front. Oncol.9, 1076 (2019).
   PubMed Web of Science ®Google Scholar
• Orso F , QuiricoL , VirgaFet al. miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer. Cancer Res.76(17), 5151–5162 (2016).
   PubMed Web of Science ®Google Scholar
• Cimino D , DePitta C , OrsoFet al. miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J.27(3), 1223–1235 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang H , YeQ , DuZet al. MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2. Biomed. Pharmacother.107, 359–367 (2018).
   PubMed Web of Science ®Google Scholar
• Nie F , LiuT , ZhongLet al. MicroRNA-148b enhances proliferation and apoptosis in human renal cancer cells via directly targeting MAP3K9. Mol. Med. Rep.13(1), 83–90 (2015).
   PubMed Web of Science ®Google Scholar
• Wu M , YeX , WangSet al. MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2. Onco. Targets Ther.10, 2815 (2017).
   PubMed Web of Science ®Google Scholar
• Qu J , ZhangL , LiL , SuY. MiR-148b functions as a tumor suppressor by targeting endoplasmic reticulum metallo protease 1 in human endometrial cancer cells. Oncol. Res.27(1), 81–88 (2018).
   PubMed Web of Science ®Google Scholar
• Li BL , LuW , QuJJet al. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis. J. Cell. Physiol.234(3), 2943–2953 (2019).
   PubMed Web of Science ®Google Scholar
• Wang G , LiZ , TianNet al. miR-148b-3p inhibits malignant biological behaviors of human glioma cells induced by high HOTAIR expression. Oncol. Lett.12(2), 879–886 (2016).
   PubMed Web of Science ®Google Scholar
• Liu SH , WangPP , Cun-TeChen DLet al. MicroRNA-148b enhances the radiosensitivity of B-cell lymphoma cells by targeting Bcl-w to promote apoptosis. Int. J. Biol. Sci.16(6), 935 (2020).
   PubMed Web of Science ®Google Scholar
• Sun N , WangCY , Sun-Qet al. Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin. Biomed. Pharmacother.106, 267–274 (2018).
   PubMed Web of Science ®Google Scholar
• Wu Y , LiuGL , LiuSHet al. MicroRNA-148b enhances the radiosensitivity of non-Hodgkin’s Lymphoma cells by promoting radiation-induced apoptosis. J. Radiat. Res.53(4), 516–525 (2012).
   PubMed Web of Science ®Google Scholar
• Sánchez-Espiridión B , Martín-MorenoAM , MontalbánCet al. Micro RNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma. Br. J. Haematol.162(3), 336–347 (2013).
   PubMed Web of Science ®Google Scholar
• Penna E , OrsoF , CiminoDet al. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. Cancer Res.73(13), 4098–4111 (2013).
   PubMed Web of Science ®Google Scholar
• Balogh J , VictorD III , AshamEHet al. Hepatocellular carcinoma: a review. J. Hepatocell. Carcinoma3, 41 (2016).
   PubMed Web of Science ®Google Scholar
• Xu Y , LiL , XiangXet al. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Gene527(2), 584–593 (2013).
   PubMed Web of Science ®Google Scholar
• Zhao Y , JiaH , ZhouHet al. Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR. Zhongguo Shi Yan Xue Ye Xue Za Zhi17(7), 526–530 (2009).
   Google Scholar
• Rath N , OlsonMF. Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. EMBO Rep.13(10), 900–908 (2012).
   PubMed Web of Science ®Google Scholar
• Ma W , WongCCL , TungEKKet al. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-Kinase/Myosin phosphatase target pathway. Hepatology57(1), 152–161 (2013).
   PubMed Web of Science ®Google Scholar
• Lin Y , XuJ , LanH. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J. Hematol. Oncol.12(1), 76 (2019).
   PubMedGoogle Scholar
• Salmaninejad A , ValilouSF , SoltaniAet al. Tumor-associated macrophages: role in cancer development and therapeutic implications. Cell Oncol.42(5), 591–608 (2019).
   PubMed Web of Science ®Google Scholar
• Song Y , XuY , WangZet al. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. IJC131(5), 1042–1051 (2012).
   Google Scholar
• Jin G , RamanathanV , QuanteMet al. Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. J. Clin. Invest.119(9), 2691–2701 (2009).
   PubMed Web of Science ®Google Scholar
• Roy J , PuttKS , CoppolaDet al. Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Oncotarget.7(12), 14605 (2016).
   PubMedGoogle Scholar
• Bray F , FerlayJ , SoerjomataramIet al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Mojtahedi A , SalehiR , NavabakbarFet al. Evaluation of apoptosis induction using PARP cleavage on gastric adenocarcinoma and fibroblast cell lines by different strains of Helicobacter pylori. PJBS10(22), 4097–4102 (2007).
   PubMedGoogle Scholar
• Jernal A , SiegelR , WardEet al. Cancer statistics, 2002. CA Cancer J. Clin.52(1), 23–47 (2002).
   PubMed Web of Science ®Google Scholar
• Li J , QinS , XuJet al. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. J. Clin. Oncol.31(26), 3219–3225 (2013).
   PubMed Web of Science ®Google Scholar
• Bläker M , ArrenbergP , StangeIet al. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT. Regul. Pept.118(1–2), 111–117 (2004).
   PubMedGoogle Scholar
• Cuq P , GrossA , TerrazaAet al. mRNAs encoding CCKB but not CCKA receptors are expressed in human T lymphocytes and Jurkat lymphoblastoid cells. Life Sci.61(5), 543–555 (1997).
   PubMed Web of Science ®Google Scholar
• Moghimi-Dehkordi B , SafaeeA , GhiasiS , ZaliM. Survival in gastric cancer patients: univariate and multivariate analysis. East. Afr. J. Public. Health. (2009).
   Google Scholar
• Boyle P , FerlayJ. Cancer incidence and mortality in Europe, 2004. Annals. Oncol.16(3), 481–488 (2005).
   PubMed Web of Science ®Google Scholar
• Rawla P , SunkaraT , BarsoukA. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przegląd. Gastroenterol.14(2), 89 (2019).
   PubMed Web of Science ®Google Scholar
• Jochem C , LeitzmannM. Obesity and colorectal cancer. In: Obesity and Cancer.KumarS, GuptaS ( Eds). Springer, Singapore, 17–41 (2016).
   Google Scholar
• Tsoi KK , PauCY , WuWKet al. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin. Gastroenterol. Hepatol.7(6), 682–688e5 (2009).
   PubMed Web of Science ®Google Scholar
• Lin TC , ChienWC , HuJMet al. Risk of colorectal cancer in patients with alcoholism: a nationwide, population-based nested case–control study. PLoS ONE15(5), e0232740 (2020).
   PubMed Web of Science ®Google Scholar
• Mohammadi A , MansooriB , BaradaranB. The role of microRNAs in colorectal cancer. Biomed. Pharmacother.84, 705–713 (2016).
   PubMed Web of Science ®Google Scholar
• Huang Z , HuangD , NiSet al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer.127(1), 118–126 (2010).
   PubMed Web of Science ®Google Scholar
• Wang S , WangL , ZhuTet al. Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors. BMC. genom.11(1), 163 (2010).
   PubMedGoogle Scholar
• Hu J , XiaX , ChengAet al. A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Mol. Cancer. Ther.7(12), 3719–3728 (2008).
   PubMed Web of Science ®Google Scholar
• Wang G , CaoX , LaiSet al. Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer. Oncogene.34(7), 912–921 (2015).
   PubMed Web of Science ®Google Scholar
• Wu Z , YuanQ , YangCet al. Downregulation of oncogenic gene TGFβR2 by miRNA-107 suppresses non-small cell lung cancer. Pathol. Res. Pract.216(1), 152690 (2020).
   PubMed Web of Science ®Google Scholar
• Lu L , LiuQ , WangPet al. MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway. BMC. Cancer19(1), 209 (2019).
   PubMedGoogle Scholar
• Yousefi M , BahramiT , SalmaninejadAet al. Lung cancer-associated brain metastasis: molecular mechanisms and therapeutic options. Cellular. Oncol.40(5), 419–441 (2017).
   PubMed Web of Science ®Google Scholar
• Yang J , LiuH , WangH , SunY. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Pathol. Res. Pract.209(8), 490–494 (2013).
   PubMed Web of Science ®Google Scholar
• Wang R , YeF , ZhenQet al. MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer. J. Physiol. Biochem.72(2), 337–343 (2016).
   PubMed Web of Science ®Google Scholar
• Kuan-Li W , TsaiYM , LienCTet al. The roles of microRNA in lung cancer. Int. J. Mol. Sci.20(7), (2019).
   Web of Science ®Google Scholar
• Yousefi M , GhaffariP , NosratiRet al. Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cellular. Oncol.43(1), 31–49 (2020).
   PubMed Web of Science ®Google Scholar
• Huang MX . Down-expression of circulating micro ribonucleic acid (miRNA)-148/152 family in plasma samples of non-small cell lung cancer patients. J. Cancer Res. Ther.12(2), 671 (2016).
   PubMed Web of Science ®Google Scholar
• Liu GL , LiuX , LvXBet al. miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA). Int. J. Clin. Exp. Med.7(8), 1990 (2014).
   PubMed Web of Science ®Google Scholar
• Ge H , LiB , HuWXet al. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Int. J. Clin. Exp. Pathol.8(1), 800 (2015).
   PubMed Web of Science ®Google Scholar
• Huang Z , ShaoleiL , YuanyuanMet al. Expression of miR-148b-3p in lung adenocarcinoma and its correlation with prognosis. Zhongguo Fei Ai Za Zhi22(5), (2019).
   Google Scholar
• Sui C , MengF , LiY , JiangY. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1 (DNMT1) expression. J. Trans. Med.13(1), 1–9 (2015).
   PubMedGoogle Scholar
• Kharbanda A , RajabiH , JinC , AlamMet al. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells. Oncotarget.5(19), 8893 (2014).
   PubMedGoogle Scholar
• Schmalhofer O , BrabletzS , BrabletzT. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev.28(1–2), 151–166 (2009).
   PubMed Web of Science ®Google Scholar
• Vigil D , KimTY , PlachcoAet al. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res.72(20), 5338–5347 (2012).
   PubMed Web of Science ®Google Scholar
• Jaeschke A , DavisRJ. Metabolic stress signaling mediated by mixed-lineage kinases. Mol. Cell.27(3), 498–508 (2007).
   PubMed Web of Science ®Google Scholar
• Momenimovahed Z , SalehiniyaH. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer11, 151 (2019).
   PubMed Web of Science ®Google Scholar
• Sandhu R , RivenbarkAG , MacklerRMet al. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer. Int. J. Oncol.44(2), 563–572 (2014).
   PubMed Web of Science ®Google Scholar
• Cuk K , ZucknickM , HeilJRet al. Circulating microRNAs in plasma as early detection markers for breast cancer. Int. J. Cancer.132(7), 1602–1612 (2013).
   PubMed Web of Science ®Google Scholar
• Shen J , HuQ , SchrauderMet al. Circulating miR-148b and miR-133a as biomarkers for breast cancer detection. Oncotarget.5(14), 5284 (2014).
   PubMedGoogle Scholar
• Dai W , HeJ , ZhengLet al. miR-148b-3p, miR-190b, and miR-429 regulate cell progression and act as potential biomarkers for breast cancer. J. Breast Cancer22(2), 219–236 (2019).
   PubMed Web of Science ®Google Scholar
• Quirico L , OrsoF , EspositoCLet al. Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression. Int. J. Biol. Sci.16(7), 1238 (2020).
   PubMed Web of Science ®Google Scholar
• Ferreira LC , OrsoF , DettoriDet al. The role of melatonin on miRNAs modulation in triple-negative breast cancer cells. PLoS ONE15(2), e0228062 (2020).
   PubMed Web of Science ®Google Scholar
• Bindra BS , KaurH , PortilloSet al. B-cell prolymphocytic leukemia: case report and challenges on a diagnostic and therapeutic forefront. Cureus11(9), (2019).
   Web of Science ®Google Scholar
• Wang H , LiuJ , XiaGet al. Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study. Sci. Rep.10(1), 1–9 (2020).
   PubMed Web of Science ®Google Scholar
• Huang BZ , StramDO , LeMarchand Let al. Interethnic differences in pancreatic cancer incidence and risk factors: the Multiethnic Cohort. Cancer. Med.8(7), 3592–3603 (2019).
   PubMed Web of Science ®Google Scholar
• Andersson G , WennerstenC , BorgquistS , JirströmK. Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study. Biol. Sex Differ.7(1), 1–11 (2016).
   PubMedGoogle Scholar
• Nie F , LiuT , ZhongLet al. MicroRNA-148b enhances proliferation and apoptosis in human renal cancer cells via directly targeting MAP3K9. Mol. Med. Rep.13(1), 83–90 (2016).
   PubMed Web of Science ®Google Scholar
• Klein AP . Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat. Rev. Gastroenterol. Hepatol.1–10 (2021).
   PubMed Web of Science ®Google Scholar
• Andersson G , WennerstenC , BorgquistS , JirströmK. Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study. Biol. Sex Differ.7(1), 66 (2016).
   PubMedGoogle Scholar
• Gupta S , WangF , HollyEA , BracciPM. Risk of pancreatic cancer by alcohol dose, duration, and pattern of consumption, including binge drinking: a population-based study. Cancer. Causes. Control21(7), 1047–1059 (2010).
   PubMed Web of Science ®Google Scholar
• Bracci PM . Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol. Carcinogene.51(1), 53–63 (2012).
   PubMed Web of Science ®Google Scholar
• Li D . Diabetes and pancreatic cancer. Mol. Carcinogene.51(1), 64–74 (2012).
   PubMed Web of Science ®Google Scholar
• Goggins M , OverbeekKA , BrandRet al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut.69(1), 7–17 (2020).
   PubMed Web of Science ®Google Scholar
• Bloomston M , FrankelWL , PetroccaFet al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA297(17), 1901–1908 (2007).
   PubMed Web of Science ®Google Scholar
• Cant C , Gerhart-HinesZ , FeigeJNet al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature458(7241), 1056–1060 (2009).
   PubMed Web of Science ®Google Scholar
• Kim EK , ParkJM , LimSet al. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells. J. Biol. Chem.286(27), 24036–24045 (2011).
   PubMed Web of Science ®Google Scholar
• Wang Z , CaiH , LinLet al. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Pediatr. Blood Cancer61(2), 206–210 (2014).
   PubMed Web of Science ®Google Scholar
• Schneider T , MawrinC , ScherlachCet al. Gliomas in adults. Deutsches. Ärzteblatt. Int.107(45), 799 (2010).
   PubMedGoogle Scholar
• Chernov AN , AlaverdianDA , GalimovaESet al. The phenomenon of multidrug resistance in glioblastomas. Hematol. Oncol. Stem. Cell. Ther. (2021).
   Google Scholar
• Ghafouri-Fard S , EsmaeiliM , TaheriM. H19 lncRNA: roles in tumorigenesis. Biomed. Pharmacother.123, 109774 (2020).
   PubMed Web of Science ®Google Scholar
• Barsyte-Lovejoy D , LauSK , BoutrosPCet al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res.66(10), 5330–5337 (2006).
   PubMed Web of Science ®Google Scholar
• Hajjari M , SalavatyA. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol. Med.12(1), 1 (2015).
   PubMed Web of Science ®Google Scholar
• Gupta RA , ShahN , WangKCet al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature464(7291), 1071–1076 (2010).
   PubMed Web of Science ®Google Scholar
• Louis D , OhgaIH , WiestlerODet al. The 2007 WHO classification of tumours of the central nervous system. Acta. Neuropathol.114, 97–109 (2007).
   PubMed Web of Science ®Google Scholar
• Khazaei Z , DehkordiAH , AmiriMet al. The incidence and mortality of endometrial cancer and its association with body mass index and human development index in Asian population. World Cancer Res. J.5, e1174 (2018).
   Google Scholar
• Nahand JS , VandchaliNR , DarabiHet al. Exosomal microRNAs: novel players in cervical cancer. Epigenomics12(18), 1651–1660 (2020).
   PubMed Web of Science ®Google Scholar
• Yousefi M , DehghaniS , NosratiRet al. Current insights into the metastasis of epithelial ovarian cancer-hopes and hurdles. Cellular. Oncol43(4), 2211–3428 (2020).
   Web of Science ®Google Scholar
• Benson EA , SkaarTC , LiuYet al. Carboplatin with decitabine therapy, in recurrent platinum resistant ovarian cancer, alters circulating miRNAs concentrations: a pilot study. PLoS ONE10(10), e0141279 (2015).
   PubMed Web of Science ®Google Scholar
• Sharifi N , SalmaninejadA , FerdosiSet al. HER2 gene amplification in patients with prostate cancer: evaluating a CISH-based method. Oncol. Lett.12(6), 4651–4658 (2016).
   PubMed Web of Science ®Google Scholar
• Salmaninejad A , GhadamiS , DizajiMZet al. Molecular characterization of KRAS, BRAF, and EGFR genes in cases with prostatic adenocarcinoma; reporting bioinformatics description and recurrent mutations. Clin. Lab.61(7), 749–59 (2015).
   PubMed Web of Science ®Google Scholar
• Watahiki A , WangY , MorrisJet al. MicroRNAs associated with metastatic prostate cancer. PLoS ONE6(9), e24950 (2011).
   PubMed Web of Science ®Google Scholar
• Arámbula-Meraz E , Bergez-HernándezF , Leal-LeNEet al. Expression of miR-148b-3p is correlated with overexpression of biomarkers in prostate cancer. Genet. Mol. Biol.43(1), (2020).
   PubMed Web of Science ®Google Scholar
• Znaor A , Lortet-TieulentJ , LaversanneMet al. International variations and trends in renal cell carcinoma incidence and mortality. Eur. Urol.67(3), 519–530 (2015).
   PubMed Web of Science ®Google Scholar
• Sellitti FD , DoiQS. MicroRNAs in renal cell carcinoma. Microrna4(1), 26–35 (2015).
   PubMedGoogle Scholar
• Yu T , WangXY , GongRGet al. The expression profile of microRNAs in a model of 7, 12-dimethyl-benz [a] anthrance-induced oral carcinogenesis in Syrian hamster. J. Exp. Clin. Cancer Res.28(1), 64 (2009).
   PubMedGoogle Scholar
• Carvalho AL , IkedaMK , MagrinJ , KowalskiLP. Trends of oral and oropharyngeal cancer survival over five decades in 3267 patients treated in a single institution. Oral. Oncol.40(1), 71–76 (2004).
   PubMed Web of Science ®Google Scholar
• Kessler P , GrabenbauerG , LeherAet al. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma: long-term survival in a prospective, non-randomized study. Br. J. Oral. Maxillofac. Surg.46(1), 1–5 (2008).
   PubMed Web of Science ®Google Scholar
• Baykul T , YilmazH , AydinUet al. Early diagnosis of oral cancer. J. Int. Med. Res.38(3), 737–749 (2010).
   PubMed Web of Science ®Google Scholar
• Stucken E , WeissmanJ , SpiegelJH. Oral cavity risk factors: experts’ opinions and literature support. Otolaryngol. Head Neck Surg.39(1), (2010).
   Web of Science ®Google Scholar
• De Aguiar FCA Jr , KowalskiLP , DeAlmeida OP. Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral. Oncol.43(6), 593–601 (2007).
   PubMed Web of Science ®Google Scholar
• Lu YC , ChenYJ , WangH-Met al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev. Res.5(4), 665–674 (2012).
   PubMed Web of Science ®Google Scholar
• Adams CM , KimAS , MitraRet al. BCL-W has a fundamental role in B cell survival and lymphomagenesis. J. Clin. Invest.127(2), 635–650 (2017).
   PubMed Web of Science ®Google Scholar
• Chauhan D , VelankarM , BrahmandamMet al. A novel Bcl-2/Bcl-X L/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma. Oncogene26(16), 2374–2380 (2007).
   PubMed Web of Science ®Google Scholar
• Sánchez-Espiridión B , Martín-MorenoAM , MontalbánCet al. Micro RNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma. Br. J. Haematol.162(3), 336–347 (2013).
   PubMed Web of Science ®Google Scholar
• Ohyashiki JH , OhtsukiK , MizoguchiIet al. Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely. Drug. Des. Devel. Ther.8, 1151 (2014).
   PubMed Web of Science ®Google Scholar
• Melnikova VO , Bar-EliM. Transcriptional control of the melanoma malignant phenotype. Cancer Biol. Ther.7(7), 997–1003 (2008).
   PubMed Web of Science ®Google Scholar
• Van Kempen LC , VanDen Oord JJ , Van MuijenGNet al. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am. J. Clin. Pathol.156(3), 769–774 (2000).
   Google Scholar
• Van Kilsdonk JW , WiltingRH , BergersMet al. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule. Cancer Res.68(10), 3671–3679 (2008).
   PubMed Web of Science ®Google Scholar
• Jannie KM , StippCS , WeinerJA. ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells. PLoS ONE7(6), e39330 (2012).
   PubMed Web of Science ®Google Scholar
• Chatzellis E , AlexandrakiKI , AndroulakisII , KaltsasG. Aggressive pituitary tumors. Neuroendocrinology101(2), 87–104 (2015).
   PubMed Web of Science ®Google Scholar
• Scheithauer BW , Kurtkaya-YapıcıerÖ , KovacsKTet al. Pituitary carcinoma: a clinicopathological review. Neurosurgery56(5), 1066–1074 (2005).
   PubMed Web of Science ®Google Scholar
• Ezzat S , AsaSL. Mechanisms of disease: the pathogenesis of pituitary tumors. Nat. Clin. Pract. Endocrinol. Metab.2(4), 220–230 (2006).
   PubMedGoogle Scholar
• Shao S , LiX. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas. J. Neurosurg. Sci.57(3), 267 (2013).
   PubMed Web of Science ®Google Scholar
• He W , HuangL , LiMet al. MiR-148b, MiR-152/ALCAM axis regulates the proliferation and invasion of pituitary adenomas cells. Cell Physiol. Biochem.44(2), 792–803 (2017).
   PubMed Web of Science ®Google Scholar
• Bowen MA , AruffoAA , BajorathJ. Cell surface receptors and their ligands: In vitro analysis of CD6-CD166 interactions. Proteins40(3), 420–428 (2000).
   PubMed Web of Science ®Google Scholar
• Weidle UH , EggleD , KlostermannS , SwartGW. ALCAM/CD166: cancer-related issues. Cancer Genom. Proteom.7(5), 231–243 (2010).
   PubMedGoogle Scholar
• Dinger ME , MercerTR , MattickJS. RNAs as extracellular signaling molecules. J. Mol. Endocrinol.40(4), 151–9 (2008).
   PubMed Web of Science ®Google Scholar
• Bader AG , BrownD , StoudemireJ , LammersP. Developing therapeutic microRNAs for cancer. Gene Ther.18(12), 1121–6 (2011).
   PubMed Web of Science ®Google Scholar
• Whitehead KA , LangerR , AndersonDG. Knocking down barriers: advances in siRNA delivery. Rev. Drug. Discov.8(2), 129–38 (2009).
   PubMed Web of Science ®Google Scholar
• Takeshita F , MinakuchiY , NagaharaSet al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc. Natl Acad. Sci. USA102(34), 12177–82 (2005).
   PubMed Web of Science ®Google Scholar
• Takeshita F , PatrawalaL , OsakiMet al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther.18(1), 181–7 (2010).
   PubMed Web of Science ®Google Scholar
• Wiggins JF , RuffinoL , KelnarKet al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res.70(14), 5923–30 (2010).
   PubMed Web of Science ®Google Scholar
• Wu Y , CrawfordM , YuB , MaoYet al. MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol. Pharm.8(4), 1381–9 (2011).
   PubMed Web of Science ®Google Scholar
• Bonci D , CoppolaV , MusumeciMet al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med.14(11), 1271–7 (2008).
   PubMed Web of Science ®Google Scholar
• Bowen MA , AruffoAA , BajorathJ. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions. Proteins40(3), 420–8 (2000).
   PubMed Web of Science ®Google Scholar
• Weidle UH , EggleD , KlostermannS , SwartGW. ALCAM/CD166: cancer-related issues. Cancer Genomics Proteomics7(5), 231–43 (2010).
   PubMedGoogle Scholar
• Trang P , MedinaPP , WigginsJFet al. Regression of murine lung tumors by the let-7 microRNA. Oncogene29(11), 1580–7 (2010).
   PubMed Web of Science ®Google Scholar
• Kota J , ChivukulaRR , O’DonnellKAet al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell137(6), 1005–17 (2009).
   PubMed Web of Science ®Google Scholar
• Maegdefessel L , AzumaJ , TohRet al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci. Transl. Med.4(122), 122ra22 (2012).
   PubMed Web of Science ®Google Scholar
• Miyazaki Y , AdachiH , KatsunoMet al. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat. Med.18(7), 1136–41 (2012).
   PubMed Web of Science ®Google Scholar